ArticleEClinicalMedicine2025
MRI-based habitat radiomics combined with vision transformer for identifying vulnerable intracranial atherosclerotic plaques and predicting stroke events: a multicenter, retrospective study.
Article in EClinicalMedicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed.
- MRI-derived habitat radiomics integrated with transformer deep learning for preoperative prediction of high CD9 expression: a novel prognostic marker in adult-type diffuse gliomas.Translational cancer research · 2026Article
- Multi-habitat radiomics on T2-FS MRI for identifying spatial patterns of axial spondyloarthritis-associated bone marrow edema.Clinical rheumatology · 2026Article
- CT-based habitat analysis combined with multi-channel deep learning for predicting early recurrence after pancreatic cancer resection: a multicenter study.Journal of translational medicine · 2026Article
- Letter to the Editor: MRI-based habitat analysis for pathologic response prediction after neoadjuvant chemoradiotherapy in rectal cancer-a multicenter study.European radiology · 2026Article
- Development and interpretation of a dual-energy CT-based deep learning radiomics model for predicting new cerebral ischemic lesions after carotid artery stenting: a multicenter study.European radiology · 2026Article
- A fusion model of deep learning and conventional features based on computed tomography angiography of carotid plaque for predicting the risk of acute ischemic stroke.Quantitative imaging in medicine and surgery · 2026Article
- Habitat imaging based on water-fat separation for interpreting extraocular muscle heterogeneity in thyroid eye disease.European thyroid journal · 2026Article
- A habitat radiomics model based on contrast-enhanced MRI for predicting early treatment response to hepatic arterial infusion chemotherapy in patients with unresectable hepatocellular carcinoma.Cellular oncology (Dordrecht, Netherlands) · 2026Article
- Habitat-aware radiomics and adaptive 2.5D deep learning predict treatment response and long-term survival in ESCC patients undergoing neoadjuvant chemoimmunotherapy.European journal of nuclear medicine and molecular imaging · 2026Article
- A CT-based multi-scale fusion model with SHAP interpretation for preoperative differentiation between lung adenocarcinoma in situ/minimally invasive adenocarcinoma and invasive adenocarcinoma: a multicenter study.Frontiers in oncology · 2026Article
- Inflammatory-neurological deficit versus metabolic dysregulation: unsupervised clustering and SHAP analysis.Frontiers in immunology · 2026Article
- Enhancing hematoma expansion prediction in hypertensive intracerebral hemorrhage based on habitat and perihematomal edema radiomics from non-contrast CT: a dual-center study.Frontiers in neuroscience · 2026Article
- Habitat imaging based on DCE-MRI for differentiating luminal and non-luminal subtypes of breast cancer: a two-center study.Frontiers in oncology · 2026Article
- Habitat imaging radiomics of chest CT identifies noninfectious acute exacerbations in chronic obstructive pulmonary disease.Frontiers in medicine · 2025Article
- A radiomics-based approach with automated segmentation for identifying symptomatic basilar artery plaques in acute stroke.Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic ResonanceArticle
- Deep learning and high-resolution magnetic resonance vascular wall imaging: current challenges and future perspectives.Frontiers in neurologyReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Accurate identification of high-risk vulnerable plaques and assessment of stroke risk are crucial for clinical decision-making, yet reliable non-invasive predictive tools are currently lacking. This study aimed to develop an artificial intelligence model based on high-resolution vessel wall imaging (HR-VWI) to assist in the identification of vulnerable plaques and prediction of stroke recurrence risk in patients with symptomatic intracranial atherosclerotic stenosis (sICAS). Methods: Between June 2018 and June 2024, a retrospective collection of HR-VWI images from 1806 plaques in 726 sICAS patients across four medical institutions was conducted. K-means clustering was applied to the T1-weighted imaging (T1WI) and T1-weighted imaging with contrast enhancement (T1CE) sequences. Following feature extraction and selection, radiomic models and habitat models were constructed. Additionally, the Vision Transformer (ViT) architecture was utilized for HR-VWI image analysis to build a deep learning model. A stacking fusion strategy was employed to integrate the habitat model and ViT model, enabling effective identification of high-risk vulnerable plaques in the intracranial region and prediction of stroke recurrence risk. Model performance was evaluated using receiver operating characteristic (ROC) curves, and model comparisons were conducted using the DeLong test. Furthermore, decision curve analysis and calibration curves were utilized to assess the practicality and clinical value of the model. Findings: The fused Habitat + ViT model exhibited excellent performance in both the validation and test sets. In the validation set, the model achieved an area under the curve (AUC) of 0.949 (95% CI: 0.927-0.969), with a sensitivity of 0.879 (95% CI: 0.840-0.945), a specificity of 0.905 (95% CI: 0.842-0.949), and an accuracy of 0.897 (95% CI: 0.870-0.926). In the test set, the AUC increased to 0.960 (95% CI: 0.941-0.973), with specificity rising to 0.963 and an accuracy of 0.885 (95% CI: 0.857-0.913). The DeLong test revealed statistically significant differences in AUC between the fused model and the single-modal models (test set, vs. ViT p = 0.000; vs. Habitat p = 0.000) Cox regression analysis showed that the Habitat + ViT index, based on the prediction probability of the Habitat + ViT model, was an independent predictor of stroke recurrence (HR: 2.07; 95% CI: 1.12-3.81), with significant predictive power for stroke events at multiple time points. Specifically, measured by AUC values, the model's predictive performance at 1, 2, 3, and 4 years was 0.751 (95% CI: 0.679-0.823), 0.820 (95% CI: 0.760-0.876), 0.815 (95% CI: 0.753-0.877), and 0.780 (95% CI: 0.680-0.873), respectively. Interpretation: The integrated Habitat + ViT model based on HR-VWI demonstrated superior performance in identifying high-risk vulnerable plaques in sICAS patients and predicting stroke recurrence risk, providing valuable support for clinical decision-making. Funding: This study was supported by the National Natural Science Foundation of China (grant 82204933). Henan Key Laboratory of Neurorestoratology (HNSJXF-2021-004), 2019 Joint Construction Project of Henan Provincial Health Committee and Ministry of Health (SB201901061), and the Xin Xiang City Acute Ischemic Stroke Precision Prevention and Treatment Key Laboratory.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.